Omada Health (NASDAQ:OMDA) Trading 15.5% Higher After Strong Earnings

Omada Health, Inc. (NASDAQ:OMDA)’s share price was up 15.5% on Friday following a better than expected earnings announcement. The stock traded as high as $22.43 and last traded at $22.5610. 563,813 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 1,229,254 shares. The stock had previously closed at $19.54.

The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The company had revenue of $87.83 million for the quarter, compared to the consensus estimate of $80.93 million.

Key Stories Impacting Omada Health

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Q2 earnings and revenue beat estimates. Omada reported quarterly adjusted earnings of $0.15 per share, versus the consensus estimate of $0.05, improving from a $0.09 loss a year earlier. Revenue reached $87.83 million, ahead of the $80.93 million analyst forecast. Omada Health Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Operating momentum remained strong. Second-quarter revenue grew 43% year over year, total members increased 45%, and gross margin reached a new quarterly record. These trends support the company’s digital chronic-care platform and suggest continued demand for its services. Omada Health Reports Second Quarter 2026 Results
• Positive Sentiment: Full-year revenue guidance exceeded expectations. Omada forecast fiscal 2026 revenue of $334 million to $340 million, above the $327.2 million consensus estimate. The outlook reinforces expectations for continued top-line growth, although the company remains only modestly profitable or loss-making under some measures. Omada Health Q2 2026 Earnings Call Transcript
• Neutral Sentiment: Leadership succession was announced. Co-founder and CEO Sean Duffy will become executive chair on January 1, 2027, while President Wei-Li Shao will become CEO. The planned transition may provide continuity, but investors could monitor execution and strategy under the new leadership. Omada Health Announces CEO Transition
• Negative Sentiment: CEO insider selling provides a minor counterpoint. Sean Duffy sold 12,944 shares for approximately $264,000, reducing his direct stake by 3.05%. The sale is relatively small compared with his remaining ownership, but insider selling can weigh modestly on sentiment. Omada Health CEO Share Sale

Analyst Upgrades and Downgrades

A number of research firms recently commented on OMDA. Barclays lifted their price target on shares of Omada Health from $20.00 to $25.00 and gave the stock an “overweight” rating in a research note on Monday. Citigroup reaffirmed an “outperform” rating on shares of Omada Health in a research report on Monday, July 20th. BTIG Research assumed coverage on Omada Health in a report on Friday, July 17th. They issued a “buy” rating and a $30.00 target price for the company. Wells Fargo & Company raised their price target on Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a research note on Friday, May 8th. Finally, Wall Street Zen lowered shares of Omada Health from a “buy” rating to a “hold” rating in a research note on Saturday, July 18th. Eleven investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $25.25.

Insider Activity

In related news, CFO Steven L. Cook sold 33,000 shares of the stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $19.89, for a total value of $656,370.00. Following the completion of the transaction, the chief financial officer directly owned 133,359 shares of the company’s stock, valued at $2,652,510.51. This trade represents a 19.84% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Sean P. Duffy sold 25,886 shares of the firm’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $22.68, for a total transaction of $587,094.48. Following the completion of the transaction, the chief executive officer directly owned 411,861 shares of the company’s stock, valued at approximately $9,341,007.48. This represents a 5.91% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 206,406 shares of company stock worth $4,191,483 over the last 90 days. 6.38% of the stock is currently owned by corporate insiders.

Institutional Trading of Omada Health

A number of hedge funds have recently modified their holdings of OMDA. Bank of New York Mellon Corp acquired a new stake in shares of Omada Health during the 2nd quarter worth approximately $1,787,000. GSA Capital Partners LLP acquired a new position in Omada Health in the 2nd quarter valued at $1,289,000. Walleye Capital LLC acquired a new stake in shares of Omada Health in the second quarter valued at about $11,648,000. Versant Capital Management Inc raised its holdings in Omada Health by 319.3% in the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after acquiring an additional 2,283 shares during the last quarter. Finally, Bank of America Corp DE lifted its stake in Omada Health by 51.5% in the 1st quarter. Bank of America Corp DE now owns 161,099 shares of the company’s stock worth $2,025,000 after purchasing an additional 54,792 shares in the last quarter.

Omada Health Price Performance

The stock has a 50 day simple moving average of $20.24 and a two-hundred day simple moving average of $16.15. The company has a market cap of $1.39 billion, a price-to-earnings ratio of -86.39 and a beta of 1.73.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.